DB
CYTK icon

Danske Bank’s Cytokinetics CYTK Stock Holding History

Danske Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Hold
200
– – ﹤0.01% 749
2026
Q1 		$13.2K Sell
200
-1,400
-88% -$89K ﹤0.01% 772
2025
Q4 		$102K Buy
1,600
+300
+23% +$18.7K ﹤0.01% 774
2025
Q3 		$71.4K Hold
1,300
– – ﹤0.01% 932
2025
Q2 		$43K Buy
1,300
+1,100
+550% +$38.3K ﹤0.01% 1070
2025
Q1 		$8.04K Hold
200
– – ﹤0.01% 1113
2024
Q4 		$9.41K Sell
200
-1,200
-86% -$62.3K ﹤0.01% 1115
2024
Q3 		$73.9K Buy
+1,400
New +$78K ﹤0.01% 1096
2024
Q2 		– Sell
-8,645
Closed -$606K – 1176
2024
Q1 		$606K Buy
+8,645
New +$669K ﹤0.01% 869

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Danske Bank's CYTK Position: Q2 2026 in Review

Danske Bank held its Cytokinetics (CYTK) position steady in Q2 2026 at 200 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Danske Bank first reported a position in CYTK in Q1 2024 and has held it in 9 quarters since. The position peaked at $606K in Q1 2024. 446 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Danske Bank held 200 shares of Cytokinetics worth $17K as of Q2 2026.
  • Danske Bank left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #749 holding.
  • Danske Bank first reported a position in Cytokinetics in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's Cytokinetics position peaked at $606K in Q1 2024.
  • 446 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.